FIM
BPMC

Fernwood Investment Management’s Blueprint Medicines BPMC Stock Holding History

Fernwood Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-404
Closed -$38.3K – 256
2024
Q1 		$38.3K Buy
+404
New +$34.6K 0.01% 368
2018
Q4 		– Sell
-2,696
Closed -$210K – 149
2018
Q3 		$210K Buy
+2,696
New +$187K 0.11% 153
2018
Q2 		– Sell
-2,696
Closed -$247K – 158
2018
Q1 		$247K Sell
2,696
-1,120
-29% -$96.5K 0.14% 125
2017
Q4 		$288K Hold
3,816
– – 0.15% 124
2017
Q3 		$266K Buy
+3,816
New +$204K 0.17% 119
2016
Q4 		– Sell
-7,000
Closed -$208K – 125
2016
Q3 		$208K Sell
7,000
-7,051
-50% -$175K 0.19% 111
2016
Q2 		$285K Buy
+14,051
New +$255K 0.28% 88

Other funds holding BPMC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fernwood Investment Management's BPMC Position: Q2 2024 in Review

Fernwood Investment Management sold out of Blueprint Medicines (BPMC) in Q2 2024, closing a stake of 404 shares — an estimated $38.3K sold.

Fernwood Investment Management first reported a position in BPMC in Q2 2016 and held it in 7 quarters. The position peaked at $288K in Q4 2017. 305 funds tracked by Wall St. Rank hold BPMC as of Q2 2024.

  • Fernwood Investment Management reported no remaining Blueprint Medicines position as of Q2 2024 after selling out during the quarter.
  • Fernwood Investment Management sold 404 Blueprint Medicines shares in Q2 2024, an estimated $38.3K.
  • Fernwood Investment Management first reported a position in Blueprint Medicines in Q2 2016 and held it in 7 quarters.
  • Fernwood Investment Management's Blueprint Medicines position peaked at $288K in Q4 2017.
  • 305 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2024.

Based on Fernwood Investment Management's 13F filing for Q2 2024, filed 31 Jul 2024.